MicroRNA profiling of paediatric AML with <i>FLT-ITD</i> or <i>MLL</i>-rearrangements: Expression signatures and <i>in vitro</i> modulation of miR-221-3p and miR-222-3p with BRD4/HATs inhibitors

Pier Paolo Leoncini(Bambino Gesù Children's Hospital), Pietro Merli(Children's Hospital of Philadelphia)
Oncology Reports
October 31, 2022
Cited by 3


Related Papers